Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
308,713,740
-
Number of holders
-
267
-
Total 13F shares, excl. options
-
279,155,505
-
Shares change
-
+757,392
-
Total reported value, excl. options
-
$6,445,326,162
-
Value change
-
+$41,955,777
-
Put/Call ratio
-
97%
-
Number of buys
-
124
-
Number of sells
-
123
-
Price
-
$23.09
Institutional Holders of AMICUS THERAPEUTICS, INC. - Common Stock (FOLD) as of Q4 2020
As of 31 Dec 2020 AMICUS THERAPEUTICS, INC. - Common Stock (FOLD) had 336 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 279,155,505 shares of stock of the company.
Largest 10 holders included PERCEPTIVE ADVISORS LLC, VANGUARD GROUP INC, BlackRock Inc., Redmile Group, LLC, MORGAN STANLEY, JANUS HENDERSON GROUP PLC, WELLINGTON MANAGEMENT GROUP LLP, Avoro Capital Advisors LLC, JPMORGAN CHASE & CO, and STATE STREET CORP.
This table shows 336 institutional shareholders of the security as of 31 Dec 2020.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.